Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Icotrokinra

Name
Icotrokinra
Molecular structural formula
CAS Number
2763602-16-8
Modification
Acetate Salt, Disulfide bond
Formula
C90H120N20O22S2
MW
1898.17
Sequence Shortening
Ac-{Pen}-NT-{Trp(7-Me)}-{Lys(Ac)}-{Pen}-{Phe(4-amino ethoxy)}-{2-Nal}-{ThpGly}-EN-{3-Pal}-{Sar}-NH2
Sequence
Ac-{Pen}-Asn-Thr-{Trp(7-Me)}-{Lys(Ac)}-{Pen}-{Phe(4-amino ethoxy)}-{2-Nal}-{ThpGly}-Glu-Asn-{3-Pal}-{Sar}-NH2
InChIKey
IVFNYXYPMJQSGF-QMRCQSNESA-N
DMSO solubility
100 mg/mL
Solubility in water
≥ 100 mg/mL
Purity
≥95%
References
[1]. Fourie AM, et al., JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans. Sci Rep. 2024 Jul 30;14(1):17515.
Target
Interleukin Related STAT
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Icotrokinra may act as an agonist of the neurotransmitter γ-aminobutyric acid (GABA), interfering with GABA-mediated central nervous system synaptic transmission, thereby leading to nerve paralysis and death of the parasite; at the same time, it can also activate glutamate-gated chloride ion channels expressed on nematode neurons and pharyngeal muscle cells, prompting neurons or muscle cells to maintain a hyperpolarized or depolarized state, thereby causing paralysis and death of the parasite.